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Background: Nanomaterials can be contaminated with endotoxin (lipopolysaccharides, LPS) during production or
handling. In this study, we searched for a convenient in vitro method to evaluate endotoxin contamination in
nanoparticle samples. We assessed the reliability of the commonly used limulus amebocyte lysate (LAL) assay and
an alternative method based on toll-like receptor (TLR) 4 reporter cells when applied with particles (TiO2, Ag,
CaCO3 and SiO2), or after extraction of the endotoxin as described in the ISO norm 29701.
Results: Our results indicate that the gel clot LAL assay is easily disturbed in the presence of nanoparticles; and
that the endotoxin extraction protocol is not suitable at high particle concentrations. The chromogenic-based LAL
endotoxin detection systems (chromogenic LAL assay and Endosafe-PTS), and the TLR4 reporter cells were not
significantly perturbed.
Conclusion: We demonstrated that nanoparticles can interfere with endotoxin detection systems indicating that a
convenient test method must be chosen before assessing endotoxin contamination in nanoparticle samples.
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Nanoparticles are worldwide produced and used in various
commercially available applications (cosmetics, paints, tex-
tiles) [1] and predictions estimate that by 2014, more than
15% of all products on the global market will have some
kind of nanotechnology incorporated into their manufac-
turing process [2]. Besides their ubiquitous lucrative
effects, also toxic effects have been reported [3]. It cannot
be excluded that nanoparticles, especially when they were
not kept sterile, can be contaminated with endotoxin
during production or handling. Therefore, endotoxin con-
tamination should be assessed when evaluating the poten-
tial toxicity, to distinguish specific nanoparticles toxicity
from the endotoxin effects.
Endotoxins or lipopolysaccharides (LPS) are large (mo-
lecular weight: 200 to 1000 kDa), heat-stable (to 100°C)
molecules that form the major structural components of
the outer cell wall of gram-negative bacteria [4,5]. High
levels of endotoxin are omnipresent in our living* Correspondence: peter.hoet@med.kuleuven.be
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reproduction in any medium, provided the orenvironment, and exposure can induce a variety of bio-
logical effects such as airway disease, fever, hypotension,
coagulopathies, septic shock and even death. Endotoxin
consists of a bioactive lipid component, termed lipid A,
covalently bound to a hydrophilic heteropolysaccharide
of variable length [6]. Induction of a signal transduction
cascade evolves binding of endotoxin on CD14 followed
by association with the protein MD2 and the transmem-
brane TLR4 [7]. This finally results in the release of in-
flammatory cytokines, including IL-1β, TNF-α and IL-6,
mainly secreted by immune cells such as macrophages
and dendritic cells.
Currently, the LAL test is the assay of choice for the
determination of endotoxin in medicines, biological
products and medical devices [5]. In general, three dif-
ferent LAL assays are used worldwide: gel clot, turbidi-
metric (increase in turbidity) and chromogenic (color
formation) assay. A good overview of the different
assays, along with their advantages and disadvantages,
can be found in the review article of Hurley [5].
In spite of the new ISO norm published in 2010 on
endotoxin test on nanomaterial samples for in vitro sys-
tems [8], not much is known in which way nanoparticlesal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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aim of our study is to find a convenient in vitro test
method to evaluate endotoxin contamination in nano-
particle samples. Therefore, in this study, we assessed
the reliability of a gel clot LAL assay, an endpoint
chromogenic LAL assay and a FDA-licensed endotoxin
detection system when performed in the presence of
nanoparticles, as well as the proposed sample prepar-
ation methods of the ISO norm were evaluated. More-
over, as an alternative for the LAL assay, we tested
another method based on TLR4 reporter cells to meas-
ure endotoxin in nanoparticle formulations.
Results
Characteristics of TiO2, Ag, CaCO3 and SiO2 particles
are summarized in Table 1, electron microscopy images
are shown in Figure 1. Transmission electron microscopy
(TEM) analysis showed average particle sizes of 15 nm
(TiO2), 25 to 85 nm (Ag), and 19 nm (SiO2). Scanning
electron microscopy (SEM) analysis of CaCO3 revealed a
very heterogeneous composition, showing particles of
both nano- and micrometer sizes. Analysis of the parti-
cles by dynamic light scattering (DLS) showed single
populations of 396 nm (TiO2), 90 nm (Ag) and 192 nm
(SiO2), and two populations of 67 and 582 nm in the
CaCO3 sample. All particles were negatively charged, the
largest electrostatic stabilization was found in the Ag
and SiO2 samples showing zeta potentials of respect-
ively −42 and −40 mV.
The results of the spiking experiments of the different
LAL assays (gel clot, endpoint chromogenic, endosafe-
Portable Test System (PTS) and endotoxin extraction
protocol) are summarized in Figure 2.
In the gel clot LAL assay, negative results (no clot for-
mation) were obtained with all particles at each concen-
tration (12.5, 50 and 200 μg/ml) both for non-baked and
baked particle samples (negative controls) (data not
shown). In the presence of non-baked particles, spiking
at half of assay sensitivity (½λ: 0.0625 EU/ml) resulted
not in clot formation (negative result) at all particle
concentrations (Figure 2A); spiking at assay sensitivity
(λ: 0.125 EU/ml) leads not to clot formation at the
highest particle concentration (200 μg/ml), while noTable 1 Characteristics of TiO2, Ag, CaCO3 and SiO2 particles
TiO2 Ag
Average TEM or SEM size (nm) 15 ± 4 From 25 (sph
80 – 90 nm
Hydrodynamic diameter (nm) 396 (P10: 164, P90: 1128) 90 (P10: 52,
Zeta potential (mV) - 25 ± 1 - 42 ±
Shape Almost spherical Some spherical
TEM/SEM size, hydrodynamic diameter, zeta potential and shape of the different pa
Hydrodynamic diameter is expressed as an intensity-weighted average with P10 (prinhibition of clot formation was seen at lower concen-
trations (12.5 and 50 μg/ml). After spiking non-baked
particles at double of assay sensitivity (2λ: 0.25 EU/ml)
no inhibition of clot formation was observed for the
TiO2 and Ag samples, whereas only an increased tur-
bidity, but no clot, was observed in CaCO3 and SiO2
at 200 μg/ml. The same results were observed for
baked spiked TiO2, Ag and CaCO3 samples.
In all samples (baked and non-baked), no (or at least
lower than the detection limit) endotoxin contamination
was measured in the endpoint chromogenic LAL assay
(data not shown). A complete spike recovery was seen
for all particle samples (non-baked and baked) at all ap-
plied concentrations (Figure 2B). Figure 3 shows the grad-
ual increase of background optical density by increasing
concentrations of TiO2 particles. A similar increase was
seen in case of the Ag particles (data not shown). The
background particle optical density was substracted from
the corresponding measured values in the endpoint
chromogenic LAL assay to obtain the final results. In the
endosafe-PTS, all particle samples showed a complete
spike recovery (within 50-200% tolerance limits) at all
concentrations (Figure 2C). In all non-spiked samples, no
(or at least lower than the detection limit) endotoxin
contamination was measured in the endosafe-PTS LAL
assay (data not shown).
The endotoxin extraction procedure was performed,
as described in the ISO protocol on endotoxin tests on
nanomaterial samples with the aim to reduce particle
assay interference. Therefore, the endotoxin concentra-
tion was measured in the supernatant after centrifuga-
tion with the endpoint chromogenic LAL assay. TiO2,
Ag and CaCO3 samples (baked and non-baked) tested
negative at all applied concentrations (0.2, 2 and 20
mg/ml) (data not shown). After spiking (0.5 EU/ml), no
endotoxin could be recovered at the highest particle
concentration (20 mg/ml) for all particles (baked and
non-baked) (Figure 2D). At lower particle concentra-
tions (0.2 and 2 mg/ml), the spike recovery was within
the tolerance range of 50-200% for all particles (baked
and non-baked), except for the non-baked Ag sample




From nano- to micrometer size 19 ± 4
P90: 121) 67 (P10: 41, P90: 139) and
582 (P10: 267, P90: 1361
192 (P10: 105, P90: 332)
0.8 - 14 ± 0.5 - 40 ± 1.1
, others rods Mixed, flakes Spherical
rticles. TEM/SEM size and zeta potential are expressed as mean ± SD.
obability 10%) and P90 (probability 90%).
Figure 1 Electron microscopy images of the different particles. Images of TiO2, Ag and SiO2 particles were obtained by transmission electron
microscopy (TEM). CaCO3 image was obtained by scanning electron microscopy (SEM).
Smulders et al. Particle and Fibre Toxicology 2012, 9:41 Page 3 of 11
http://www.particleandfibretoxicology.com/content/9/1/41TLR4 reporter cells were used to evaluate the influ-
ence of the particles on TLR4-activation by endotoxin.
Figure 4 shows the responsiveness of the cells to increas-
ing concentrations of endotoxin. TLR4 reporter cells
already show an increased response starting at an
endotoxin concentration of 0.05 EU/ml. Assuming this
dose–response relationship, the half maximum effective
concentration (EC50) was determined (0.3 EU/ml), caus-
ing a response ratio of about 4, and this concentration
was chosen for spiking (½λmax). Also the biological func-
tionality (TNF-α release) of the cells was assessed. No
increase in TNF-α release was observed after exposure
to endotoxin (See in Additional file 1: Figure S1).
Exposing the cells to the particles (non-baked and
baked), did not result in a measurable response with in-
creasing concentrations of particles in all cases (Figure 5
(grey lines)). Spiking (½λmax) the particles (positive con-
trol) resulted in a higher response compared to the re-
spective non-spiked samples at all particle concentrations
and approximates the response observed at the endotoxin
EC50 value (response ratio of approximately 4), indicating
a complete spike recovery (Figure 5 (green lines) and
Figure 6). Moreover, an increased response was seen in
the spiked TiO2 and CaCO3 samples at a concentration
of 200 μg/ml compared to the respective spiked sample
without particles, which was significant in the case ofTiO2 (baked) and CaCO3 (non-baked and baked). Applying
an endotoxin inhibitor (polymyxin B sulfate, 100 μg/ml) in
the presence of spiked particles resulted in a complete in-
hibition of the response at all particle concentrations
(Figure 5 (red lines)). Regarding Ag, significant cytotox-
icity was observed at concentrations above 50 μg/ml and
therefore, measurements were limited in this case.
Discussion
In the present study, we investigated the performance of
different LAL assays in the presence of nanoparticles
and evaluated another – non LAL-based – in vitro assay
to assess endotoxin contamination. We have shown that
nanoparticles have the potential to interfere with the gel
clot LAL assay at elevated – but not excessive high –
particle concentrations. Likewise, an endotoxin extrac-
tion protocol, including shaking and centrifugation of
the particle dispersion, seems to be unsatisfactory at
high particle concentrations. Furthermore, we also
demonstrated that chromogenic-based LAL endotoxin
detection systems (chromogenic LAL assay and Endosafe-
PTS) and TLR4 reporter cells report no interfering effects
at all applied particle concentrations.
Over the past decades, the LAL assay has been found
an application in various domains, ranging from the phar-





Spiking ½λmax (0.5 EU/ml)
NP 0 12.5 50 200
TiO2 100 82 86 81
Ag 100 88 97 92
CaCO3 100 97 102 104
SiO2 100 87 88 92
C 
Endosafe-PTS
Spiking (internal spiking) 
NP 0 12.5 50 200
TiO2 82 90 98 90
Ag 82 /////// /////// 70
CaCO3 82 /////// /////// 112
SiO2 82 /////// /////// 87
D 
Gel Clot – non-baked samples
Spiking ½λ (0.0625 EU/ml) (0.125 EU/ml) 2λ (0.25 EU/ml)





Gel Clot – baked samples
Spiking ½λ (0.0625 EU/ml) (0.125 EU/ml) 2λ (0.25 EU/ml)






Spiking ½λmax (0.5 EU/ml)
NP 0 12.5 50 200
TiO2 100 88 84 81
Ag 100 90 91 85
CaCO3 100 102 99 96
Extraction protocol
non-baked samples
Spiking ½λmax (0.5 EU/ml)
NP (mg/ml) 0 0.2 2 20
TiO2 100 97 89 0 
Ag 100 98 22 0 
CaCO3 100 135 115 0 
Extraction protocol
baked samples
Spiking ½λmax (0.5 EU/ml)
NP (mg/ml) 0 0.2 2 20
TiO2 100 89 88 7 
Ag 100 95 85 0 
CaCO3 100 81 78 0
λ
λ
Figure 2 Overview of the different LAL assays when performed in the presence of particles (12.5, 50 and 200 μg/ml or 0.2, 2 and 20
mg/ml) after spiking. A: Gel clot LAL assay; B: Endpoint chromogenic LAL assay; C: Endosafe-Portable Test System (PTS); D: Endpoint
chromogenic after endotoxin extraction (shaken 10 min and centrifugation). Samples spiked with endotoxin concentrations half of assay
sensitivity (½λ: 0.0625 EU/ml), assay sensitivity (λ: 0.125 EU/ml) and double of assay sensitivity (2λ: 0.25 EU/ml) (gel clot LAL assay); half of
maximum of assay range (½λmax: 0.5 EU/ml) (endpoint chromogenic LAL assay); the endosafe-PTS contains an internal spiking control. Results are
shown in a heat plot: Red: no clot (Gel Clot) or no spike recovery (chromogenic assays); Yellow: increased turbidity (Gel Clot); Green: clot
formation (Gel Clot) or complete spike recovery (chromogenic assays). Percentages indicate percentage spike recovery. In case of the endosafe-
PTS, measurements of Ag, CaCO3 and SiO2 samples were not performed at the lower particle concentrations (12.5 and 50 μg/ml), because the
highest concentration (200 μg/ml) showed a complete spike recovery.
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Figure 3 Optical density by increasing concentrations of TiO2
particles in the endpoint chromogenic LAL assay. Open symbols
show optical density (OD405nm) of TiO2 particles, while closed
symbols show the OD of spiked TiO2 particles. The dotted line
shows the corrected OD after spiking: OD(spiked particles) – OD
(particles).
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ducts has been extensively studied and it is known that
certain body fluids (e.g. urine and blood) can influence
the outcome of the LAL assay [5,11]. A study carried
out by the FDA almost 30 years ago showed that out



















Figure 4 Dose–response curve of TLR4 reporter cells without
and with endotoxin inhibitor. Black line shows response ratio of
TLR4 reporter cells by increasing concentrations of endotoxin. Red
line shows response ratio when applied with endotoxin inhibitor
(polymyxin B sulfate, 100 μg/ml). EC50: Half maximum effective
concentration.with the LAL assay when applied prior to any dilution
[12]. Surprisingly, almost no research has been done to
which extent nanoparticles can interfere with the different
LAL assays. Recently, Dobrovolskaia et al. published the
first study showing that endotoxin levels can be under- or
overestimated due to the presence of nanoparticles [9].
Interference can occur when endotoxin interferes with
the particles or when particles interfere with the LAL
specific enzymes resulting in the decrease or increase of
the sensitivity of the assay. Therefore, appropriate inhib-
ition/enhancement controls are essential to recognize
whether negative results are due to absence of endo-
toxin, or inhibition of the assay. According to the United
States, European and Japanese pharmacopeia, a test is
considered valid if the measured concentration of endo-
toxin added falls within the tolerance range of 50-200%
of the known added endotoxin concentration [13-15].
Appropriate spiking concentrations need to be chosen
dependent on the applied LAL assay and its associated
sensitivity.
The gel clot LAL assay is quite easy to perform, but
limitations are the subjective endpoint and the relative
lack of sensitivity. In our study, endotoxin spiking
concentrations were chosen below (50% assay sensitiv-
ity; ½λ: 0.0625 EU/ml), at (100% assay sensitivity; λ:
0.125 EU/ml) and above (200% assay sensitivity; 2λ:
0.25 EU/ml) the sensitivity of the assay. In this way,
we were able to assess whether potential interference
was situated in- or outside the tolerable limits. Two
of four tested particles, SiO2 and CaCO3, fall out of
this range and exert substantial inhibitory effect on
the gel clot LAL assay, at the highest particle concen-
tration tested (200 μg/ml). However, the other tested
particles, TiO2 and Ag, show inhibitory effects as well,
but only at spiking concentrations at the sensitivity of
the assay (λ), and fall therefore within the 50-200%
limits. Similarly, in the study of Dobrovolskaia et al.,
3 of the 5 tested particle formulation interfered with
the gel clot LAL assay [9]. Dilution is the simplest
and most widely used technique to overcome interfer-
ence, in our experiments no more inhibitory effects
were seen after diluting to particle concentrations of
50 and 12.5 μg/ml. Important to note is that particle con-
centrations of about 200 μg/ml are often used in toxico-
logical research [16,17], thus adequate endotoxin detection
methods at this concentration are indispensable.
The chromogenic-based LAL assays (chromogenic
LAL assay and the Endosafe-PTS) are, compared to the
semiquantitative gel clot LAL assay, more quantitative.
Neither in the chromogenic LAL assay, nor in the
Endosafe-PTS, any significant interfering effect due to
the presence of the particles were observed at the
highest applied concentration (200 μg/ml), suggesting
that chromogenic-based LAL methods are convenient
TiO2 (non-baked)
















































































































o Particles + endotoxin (0.3 EU/ml)
Particles





Figure 5 (See legend on next page.)
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Figure 5 Response ratio of TLR4 reporter cells when applied with particles. The response ratio of TLR4 reporter cells after exposure to
increasing concentration of particles (0, 12.5, 50 and 200 μg/ml) (grey line), spiked (0.3 EU/ml) particles (green line) and spiked particles +
endotoxin inhibitor (polymyxin B sulfate, 100 μg/ml) (red line). A: TiO2 particles (non-baked and baked); B: CaCO3 particles (non-baked and
baked); C: Ag particles (non-baked and baked); D: SiO2 particles (non-baked).
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http://www.particleandfibretoxicology.com/content/9/1/41for endotoxin testing in particle samples. However, at
increasing concentrations of certain particles, in our
study in particular the TiO2 and Ag particles, a grow-
ing background color/optical density has to be taken
in account. The increase of optical density, caused by
the particles, could therefore be misinterpreted as in-
creasing levels of endotoxin. Oostingh et al. reached
the same conclusion regarding the use of spectophoto-
metric detection techniques in the case of nanoparticle
samples [18]. They showed that Au nanoparticles,
already at very low concentrations (starting from 1 μg/
ml), significantly interfered with the spectophotometric
readout in the endpoint chromogenic LAL assay.
Therefore, background optical density should always be
substracted from their respective measured value. At
too high particle concentrations, measurements can
become unreliable and in this case another endotoxin
detection method needs to be considered.
In 2010, ISO published an international standard on
endotoxin test on nanomaterial samples for in vitro sys-
tems (LAL test), including an endotoxin extraction
method [8]. Comparable procedures are already per-
formed to extract endotoxin from air filters and dust
particles [19,20]. Usually, water is the extraction
medium, other media like polysorbate 20 can be used
but these can interfere with the LAL assay. As men-
tioned above, particles can interfere with spectophoto-
metric detection methods and therefore, in the
endotoxin extraction experiments, we chose to work
with higher particle concentrations (up to 20 mg/ml). In
our study, extraction in water lead to a complete spikeTLR4 reporter cells
non-baked samples
Spiking ½λmax (0.3 EU/ml)
NP (mg/ml) 0 12.5 50 200
TiO2 100 101 100 116
Ag 100 95 95
CaCO3 100 98 107 126
SiO2 100 97 98 93
Figure 6 TLR4 reporter cells when performed in the presence of part
endotoxin concentrations half of assay sensitivity (½λmax: 0.3 EU/ml). Resul
spike recovery (between 50 and 200%). Percentages indicate percentage sprecovery at the two lowest particle concentrations (0.2
and 2 mg/ml) in most samples, suggesting this proced-
ure is adequate for many nanoparticle suspensions.
However, at very high particle concentrations (20 mg/
ml) no endotoxin could be recovered indicating the lim-
itations of this technique. Furthermore, particles that do
not pellet during classical centrifugation are not suitable
for this method.
Knowing that nanoparticles are coated with proteins
when entering a biological fluid (e.g. blood, plasma) [21],
it cannot be excluded that endotoxin and/or LAL pro-
teins bind on the particle surface, possibly resulting in
modification/inactivation of those attached molecules.
However, as demonstrated interfering effects were only
seen in the gel clot LAL assay, not in the chromogenic-
based LAL assays, suggesting gel clot specific proteins
are probably involved in the inhibitory effects. We
hypothesize that interaction between the particles and
the coagulogen protein or its activated counterpart (coa-
gulin) causes the observed inhibitory effects in the gel
clot LAL assay. Likewise, the unsuitability of the endo-
toxin extraction protocol at high particle concentrations,
in our hand above 2 mg/ml, can be attributed to the
attached endotoxin does not wash off during shaking or
(a part of ) the free endotoxin ends up in the pellet, cap-
tured in a matrix of particles, after centrifugation.
The lipid A component represents the toxic and
immunomodulating domain of endotoxin and it is the
part of the molecule that is reactive in both the LAL
assay and in vivo after binding on the TLR4 receptor [7].
TLR4 reporter cells are widely used to screen andTLR4 reporter cells
baked samples
Spiking ½λmax (0.3 EU/ml)
NP (mg/ml) 0 12.5 50 200
TiO2 100 101 107 123
Ag 100 107 107
CaCO3 100 98 105 134
icles (12.5, 50 and 200 μg/ml) after spiking. Samples spiked with
ts are shown in a heat plot: Red: no spike recovery; Green: complete
ike recovery.
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ledge, we are the first that used TLR4 reporter cells as a
tool to evaluate endotoxin contamination, and the po-
tential interference of nanoparticles. We observed a
complete spike recovery in all samples when exposing
the TLR4 reporter cells to increasing concentration of
spiked particles, indicating that TLR4 reporter cells can
be used as a replacement for the commonly used LAL
assay. Because TLR reporter cells already show an
increased response starting at an endotoxin concentra-
tion of 0.05 EU/ml, the sensitivity is comparable to those
of the LAL assay. However, nanoparticles can exert cyto-
toxic effects on the TLR4 reporter cells, limiting the
measurements above particle cytotoxicity.
Furthermore, an increased response was seen in the
spiked TiO2 (baked) and CaCO3 (non-baked and baked)
samples at the highest concentration compared to the re-
spective spiked samples without particles. We reasoned
that sedimentation of the particles on the cells during
incubation results in higher concentrations of particles,
accompanied by higher concentrations of endotoxin
bound on the particles and/or endotoxin captured in the
matrix of the particles, in close proximity of the cells. Re-
cently, Cho et al. demonstrated that particles can sedi-
ment, which means that the concentrations of particles
on the cell surface at the bottom of a culture plate may
be higher than the initial bulk concentration, and this
could lead to increased activation or uptake by cells [22].
To produce LAL assays, horseshoe crabs are caught,
bled and then returned to the ocean alive. Through-
out this process, the crabs are exposed to a variety of
potential stressors, such as air exposure, increased
temperature, handling and blood loss [23]. Mortality
associated with the collection and bleeding procedures
may not be neglected, several studies have estimated
mortality rates between 8 and 20% [23-26]. From an
economic and ethical perspective, alternative endo-
toxin detection methods should be considered if avail-
able. From this point of view, TLR4 reporter cells can
potentially be used as an alternative for the commonly
used LAL assay, however, drawbacks are potential
cytotoxicity and the relative long measurement time.Conclusion
In conclusion, our results indicate that nanoparticles
(TiO2, Ag, CaCO3, SiO2) can interfere with certain endo-
toxin detection methods (gel clot LAL assay, endotoxin
extraction protocol), while other assays (chromogenic-
based LAL assay, TLR4 reporter cells) are not hampered.
Dependent on the particle and its concentration used, a
convenient endotoxin detection test method must be
chosen.Methods
Materials
Ag and CaCO3 powders were provided by PPG Europe
BV (The Netherlands), while TiO2 powder and SiO2, in
suspension at a concentration of 370 mg/ml, were
obtained from respectively Materis Paints Italia (Italy)
and Akzo Nobel Coatings S.A. (The Netherlands). The
gel clot PYROGENTW Plus LAL assay and the endpoint
chromogenic QCL-1000W LAL assay were purchased
from Lonza (Verviers, Belgium). The EndosafeW-Portable
Test System (PTS) Cartridges were purchased from Charles
River (Wilmington, United States). HEK-Blue™ hTLR4
(TLR4 reporter) cells, QUANTI-Blue™ and 250X HEK-
Blue™ Selection were obtained from Invivogen (Toulouse,
France), while endotoxin inhibitor (polymyxin B Sulfate)
was purchased from Calbiochem (Darmstadt, Germany).
Dulbecco’s Modified Eagle Medium (DMEM), fetal bovine
serum (FBS), penicillin–streptomycin (10,000 U/ml and
10,000 μg/ml), fungizone, L-glutamine (200 mM) were pur-
chased from Invitrogen (Merelbeke, Belgium). Endotoxin
(E. coli strain O111:B4) was purchased from Sigma Aldrich
(Bornem, Belgium).Particle characterization
DLS
TiO2, Ag, CaCO3 and SiO2 particles were diluted in
water to concentrations of respectively 8, 20, 40 and
400 μg/ml. DLS measurements were performed with a
Brookhaven 90 Plus NanoParticle Size Distribution
Analyser (scattering angle 90 u, wavelength 659 nm,
power 15 mW; Brookhaven Instruments Ltd, Redditch,
UK). Correlation functions were analysed using the Clem-
entine package (maximum entropy method) for Igor Pro
6.02A (WaveMetrics, Portland, OR, USA). This resulted
in intensity-weighted distribution functions versus decay
times. By converting the decay times with instrument
parameters and physical parameters to hydrodynamic
diameters, an intensity-weighted size distribution is
obtained. A log-normal fit was applied to each population,
resulting in the intensity-weighted average hydrodynamic
diameter of the population.Zeta potential
The zeta potential was measured in distilled water using
a Brookhaven 90Plus/ZetaPlus instrument applying elec-
trophoretic light scattering. A primary and reference
beam (659 nm, 35 mW), modulated optics and a dip-in
electrode system were used. The frequency shift of scat-
tered light (relative to the reference beam) from a
charged particle moving in an electric field is related to
the electrophoretic mobility of the particle. The
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tential from the electrophoretic mobility.
TEM
Suspensions of the SiO2 particles were applied on
formvar-coated cupper mesh grids. After drying over-
night, the particles were characterized by transmission
electron microscopy (TEM) (JEOL JEM-1200 EX-II,
Tokyo, Japan) at a magnification of 20.000-200.000 x.
TiO2 and Ag pristine particles were suspended in etha-
nol, and a 5 μl drop of these dispersions were then
deposited on a holey carbon film supported on 3 mm
copper grids for TEM investigations. After solvent evap-
orating at room temperature, grids were dried overnight
at dark at 25°C. Size and shape of particles were deter-
mined by using JEOL JEM - 3010 TEM, operating at
300 kV, with a high-resolution pole piece (0.17 nm point
to point resolution) and equipped with Energy Dispersive
X-ray Spectroscopy (EDS) detector (Oxford Link ISIS).
SEM
The CaCO3 powder was applied on aluminum stubs
covered with self-adhesive carbon tabs (G3347N, Agar
Scientific, Essex, UK) and was subsequently character-
ized by SEM (Jeol JSM-6610 LV).
General strategy
To cover a broad spectrum of in vitro endotoxin detection
methods, different types of LAL assays - gel clot, endpoint
chromogenic and kinetic chromogenic (Endosafe-PTS) -
were used to evaluate the potential endotoxin contamin-
ation in the particle samples. In addition to the LAL assay,
a cell-based method (TLR4 reporter cells) was tested on its
potential to detect endotoxin in the presence of particles.
The powder samples (TiO2, Ag and CaCO3) were
baked for 4 h at 200°C to remove all endotoxin (negative
controls).
To study the effect of the particles on the endotoxin
detection, the samples (baked and non-baked) were
spiked with different amounts of endotoxin in the different
assays (positive controls).
Sample preparation
Powder samples (TiO2, Ag and CaCO3) were prepared
by suspending the particles in endotoxin-free water and
a dilution series (0, 12.5, 50 and 200 μg/ml) was made in
case of the gel clot LAL assay, endpoint chromogenic
LAL assay, the Endosafe-PTS LAL assay and the experi-
ments with TLR4 reporter cells. Dilutions of the SiO2
suspension were prepared to reach equal concentrations.
In addition, sample suspensions were prepared at con-
centrations of 0.2, 2 and 20 mg/ml and subsequently
vortexed thoroughly, shaken (10 min) and centrifuged
(2 min, 1000 g) to extract endotoxin, according to theISO protocol (ISO 29701) [8]. The supernatant served as
sample in the endpoint chromogenic LAL assay. In two
preliminary tests, we verified whether endotoxins will
pellet in particle free samples, possibly resulting in an
underestimation of the contamination, and whether par-
ticles pellet during centrifugation. This clearly showed
that endotoxin in suspension will not simply pellet and
remained easily detectable (data not shown). TiO2, Ag
and CaCO3 clearly pellet during centrifugation, while SiO2
particles remained in suspension during centrifugation
(see in Additional file 1: Figure S2), and therefore no
endotoxin extraction experiments were performed with
SiO2 particles.
LAL assay
The LAL assay is based on clottable proteins present in the
blood cells (amebocytes) of the horseshoe crab (Limulus
polyphemus) as described by Levin and Bang [27-29].
Gel Clot assay
In the gel clot LAL assay, activation of a preclotting en-
zyme cleaves the coagulogen protein to form a gelatin-
ous clot. LAL reagent is added to an equal volume of
sample and the formation of a clot is determined. The
sensitivity of the gel clot LAL assay we used was 0.125
EU/ml, thus samples were spiked with endotoxin (E.
coli strain O55:B5) concentrations half of assay sensi-
tivity (½λ: 0.0625 EU/ml), assay sensitivity (λ: 0.125
EU/ml) and double of assay sensitivity (2λ: 0.25 EU/ml).
Measurements were performed according to the
manufacturer’s instructions.
Endpoint chromogenic LAL assay
In the chromogenic LAL assay, the coagulogen protein
is replaced by a chromogenic substrate, a small peptide
linked to a chromophore (p-nitroaniline) containing
amino acid sequence, which can be cleaved by the clot-
ting enzyme. The (yellow) color generated by cleavage of
the substrate, as measured spectrophotometrically at 405
nm, is proportional to the amount of endotoxin in the
sample. In the endpoint chromogenic LAL assay, the
endotoxin concentration is measured once after a fixed
time. The detection range was from 0.1 to 1.0 EU/ml,
samples were spiked with an endotoxin (E. coli strain
O111:B4) concentration in between this range (½λmax:
0.5 EU/ml). Measurements were performed according to
the manufacturer’s instructions.
Endosafe-PTS
The Endosafe-PTS LAL assay is a FDA-licensed endo-
toxin detection system. The LAL assay cartridges con-
tain four channels to which LAL reagent and a
chromogenic substrate have been applied. Two of the
four channels contain an endotoxin spike and serve as
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spike recovery are considered to be acceptable. The
sensitivity of the assay we used was 0.05 EU/ml.
TLR4 reporter cells
TLR4 reporter cells were obtained by co-transfection of
the human TLR4 (hTLR4) and MD-2/CD14 co-receptor
genes and an optimized secrected embryonic alkaline
phosphatase (SEAP) reporter gene under the control of
a promoter (IL-12 p40) inducible by the transcription
factors NF-ĸB and activator protein 1 (AP-1). TLR4
stimulation causes SEAP production, which can be easily
determined spectophotometrically by QUANTI-BlueTM.
TLR4 reporter cells were grown in DMEM supplemen-
ted with 5% (v/v) FBS, 100 U/ml penicillin, 100 μg/ml
streptomycin, 1.25 μg/ml fungizone, 2 mM L-glutamine
and 1X HEK-Blue™ Selection.
HEK-TLR4 cells were exposed to a dilution series of
endotoxin (E. coli strain O111:B4) to generate a dose re-
sponse curve, the half maximum effective concentration
(EC50) was determined which served as spiking
concentration (½λmax). Measurements were performed
according to the manufacturer’s instructions. Shortly,
each sample was added to ~25,000 cells in a flat-bottom
96- well plate. After incubation for 22 h (at 37°C, 5%
CO2), the cell supernatant was added to QUANTI-
Blue™. After incubation for 2 h, SEAP levels were mea-
sured spectophotometrically at 655 nm.
In preliminary experiments, we assessed the cytotox-
icity of TLR4 reporter cells after exposure to polymyxin
B Sulfate (100 μg/ml) or nanoparticles. Polymyxin B sul-
fate, TiO2, SiO2 and CaCO3 did not cause significant cell
death, while cytotoxicity was observed after Ag exposure
only at highest concentration (200 μg/ml).
Data reporting - presentation
According to the United States, European and Japanese
pharmacopeia, a test is considered valid if the measured
concentration of endotoxin added falls within the tolerance
range of 50-200% of the known added endotoxin
concentration [13-15].
Additional file
Additional file 1: Figure S1. TNF-α release of TLR4 reporter cells after
exposure to different concentrations of endotoxin. Figure S2. Pictures of
particle samples (20 mg/ml) after centrifugation (2 min, 1000 g).
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